glp-1 in development What is the pipeline for future medications for obesity? GLP-1 Reporter Cells | Incretin
Description
[DOI] [PMC free article] [PubMed] [Google Scholar] 37.Farrs J., Pujol A., Coma M., Ruiz J.L., Naval J., Mas J.M., Molins A., Fondevila J., Aloy P
GLP-1 medications, such as Ozempic, Wegovy, Mounjaro, and Zepbound are now prescribed commonly for people diagnosed with Type 2 diabetes and/or obesity
Cambiar hbitos
However, data is extremely limited
However, these effects are typically small and inconsistent across studies, and the mechanisms remain poorly understood
There were no ICP lowering agents or addition of headache preventative drugs started during the study
